• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BTC Network rebrands, acquires Novex Clinical Research

BTC Network rebrands, acquires Novex Clinical Research

August 2, 2016
CenterWatch Staff

BTC Network, a fully integrated network of clinical research sites in the U.S., has strengthened its site operations with the recent acquisition of Novex Clinical Research, a multi-specialty research practice in New Bedford, Massachusetts. As a result of the deal, Novex Clinical Research will be the first clinical research site to be owned and operated under the BTC Network umbrella. It will strengthen BTC Network’s expertise and commitment to therapeutic areas such as psychiatry, neurology, pain, and internal medicine.

Novex Clinical Research has proven its clinical trial expertise with its board-certified physician investigators and professional research coordinators that have managed nearly 300 clinical studies. Novex, as a top enroller and one of the premier industry leaders in psychiatry, neurology and pain, provides BTC Network with a great opportunity to strengthen its access to relevant studies. Novex Clinical Research will now be known as BTC of New Bedford.

Since announcing a rebranding ahead of the DIA conference in Philadelphia in June 2016, BTC Network has been quickly growing its owned and affiliated site model across the U.S. The company, which until recently was known as BlueTheory Clinical Trials, has been experiencing significant growth through its integrated site network or PRIME Network Model, which provides exclusive relationships and centralized processes at a growing number of facilities across the U.S. The acquisition of Novex allows BTC Network to offer customers access to over ten thousand potential patients within relevant therapeutic areas.

Scott Palmese, BTC Network’s director of Clinical Operations, said, “Novex Clinical Research shares BTC Network’s progressive views and, by combining, we can enhance our ability to scale our know-how, infrastructure, and healthcare relationships to bring more of the right trials to the right patients. Together we will enhance the execution of clinical trials and deliver greater value for both the industry and health care systems, forging better and closer connections. The ultimate beneficiary of this work will be patients, through lower cost of care, improved clinical outcomes, and enhanced patient experiences.”

Christian Burns, vice president of BTC Network and president of ClinEdge (sister company to BTC Network), stated, “BTC Network already has a strong footprint in the U.S. This latest acquisition is important as it marks BTC Network’s entry into the site ownership space, giving us a diverse range of therapeutic capabilities and services for our sponsor and CRO clients. Novex Clinical Research’s reputation, commitment to patients, and diverse range of experience aligns nicely with our organization’s future goals.”

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing